Home/Supreme Court/Amgen Inc. v. Sandoz Inc.

Amgen Inc. v. Sandoz Inc.

137 S. Ct. 808, 196 L. Ed. 2d 594, 85 U.S.L.W. 3343, 2017 WL 125662, 2017 U.S. LEXIS 685
Supreme Court of the United States·Decided January 13, 2017·No. No. 15–1195.·Published

Opinion

Motion of Apotex, Inc., et al. for leave to file a brief as amici curiae granted. Petition for writ of certiorari to the United States Court of Appeals for the Federal Circuit granted. The case is consolidated and a total of one hour is allotted for oral argument.

Free access — add to your briefcase to read the full text and ask questions with AI

Amgen Inc. v. Sandoz Inc., 137 S. Ct. 808, 196 L. Ed. 2d 594, 85 U.S.L.W. 3343, 2017 WL 125662, 2017 U.S. LEXIS 685 (U.S. 2017).

137 S. Ct. 808 (Amgen Inc. v. Sandoz Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.